CETAMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Cetamide patents expire, and what generic alternatives are available?
Cetamide is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in CETAMIDE is sulfacetamide sodium. There are three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cetamide
A generic version of CETAMIDE was approved as sulfacetamide sodium by SANDOZ on October 18th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CETAMIDE?
- What are the global sales for CETAMIDE?
- What is Average Wholesale Price for CETAMIDE?
Summary for CETAMIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| DailyMed Link: | CETAMIDE at DailyMed |
US Patents and Regulatory Information for CETAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon | CETAMIDE | sulfacetamide sodium | OINTMENT;OPHTHALMIC | 080021-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
